| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |